Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Single-use vial of Vitrase approved for use as spreading agent

Dec. 9, 2004

GenVec licenses PEDF rights for ocular diseases

Dec. 2, 2004

Putative melatonin receptor agonist promising for treatment of glaucoma

Nov. 30, 2004

Sirna-027 enters phase I study for wet AMD

Nov. 25, 2004

Merck claims prostaglandin analogues as EP4 receptor agonists for ocular and bone conditions

Nov. 24, 2004

CA4P enters phase II study

Nov. 23, 2004

ISTA licenses U.S. rights for ecabet sodium for dry eye

Nov. 22, 2004

Disappointing preliminary results of Trabio study

Nov. 12, 2004

Use of diazoxide for treatment of ischemia retinae claimed in CNRS patent

Nov. 11, 2004

New clinical data on the efficacy of SnET2 photodynamic therapy in AMD

Nov. 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...